Below are the 10 most expensive drugs in the U.S., along with their annual cost, based on length of therapy.
- Zolgensma (AveXis): $2,125,000
- Zokinvy (Eiger BioPharmaceuticals): $1,032,480
- Danyelza (Y-mAbs Therapeutics): $977,664
- Myalept (Aegerion Pharmaceuticals): $889,904
- Luxturna (Spark Therapeutics): $850,000
- Folotyn (Acrotech Biopharma): $793,870
- Brineura (BioMarin Pharmaceuticals): $730,340
- Blincyto (Amgen): $712,672
- Ravicti (Horizon Therapeutics): $695,970
- Soliris (Alexion Pharmaceuticals): $678,392
More articles on pharmacy:
Amgen acquires cancer drugmaker for $1.9B
Moderna vaccine causing delayed rash in some recipients, small study says
AmerisourceBergen awards CEO $14.3M pay package despite $6.6B opioid settlement
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
